Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1985 2
1986 4
1987 1
1988 2
1989 1
1990 5
1991 3
1992 1
1993 7
1994 9
1995 7
1996 8
1997 8
1998 11
1999 9
2000 11
2001 18
2002 16
2003 21
2004 22
2005 25
2006 14
2007 20
2008 13
2009 18
2010 19
2011 18
2012 20
2013 10
2014 20
2015 19
2016 17
2017 20
2018 25
2019 23
2020 44
2021 32
2022 27
2023 25
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Results by year

Filters applied: . Clear all
Page 1
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.
Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, Brusselle G, Cruz AA, Drazen JM, Duijts L, Fleming L, Inoue H, Ko FWS, Krishnan JA, Mortimer K, Pitrez PM, Sheikh A, Yorgancıoğlu A, Reddel HK. Levy ML, et al. Among authors: buhl r. NPJ Prim Care Respir Med. 2023 Feb 8;33(1):7. doi: 10.1038/s41533-023-00330-1. NPJ Prim Care Respir Med. 2023. PMID: 36754956 Free PMC article. Review.
Disease-modifying anti-asthmatic drugs.
Lommatzsch M, Brusselle GG, Canonica GW, Jackson DJ, Nair P, Buhl R, Virchow JC. Lommatzsch M, et al. Among authors: buhl r. Lancet. 2022 Apr 23;399(10335):1664-1668. doi: 10.1016/S0140-6736(22)00331-2. Lancet. 2022. PMID: 35461560 Review. No abstract available.
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes.
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Reddel HK, et al. Among authors: buhl r. Eur Respir J. 2021 Dec 31;59(1):2102730. doi: 10.1183/13993003.02730-2021. Print 2022 Jan. Eur Respir J. 2021. PMID: 34667060 Free PMC article. Review.
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.
Bousquet J, Melén E, Haahtela T, Koppelman GH, Togias A, Valenta R, Akdis CA, Czarlewski W, Rothenberg M, Valiulis A, Wickman M, Akdis M, Aguilar D, Bedbrook A, Bindslev-Jensen C, Bosnic-Anticevich S, Boulet LP, Brightling CE, Brussino L, Burte E, Bustamante M, Canonica GW, Cecchi L, Celedon JC, Chaves Loureiro C, Costa E, Cruz AA, Erhola M, Gemicioglu B, Fokkens WJ, Garcia-Aymerich J, Guerra S, Heinrich J, Ivancevich JC, Keil T, Klimek L, Kuna P, Kupczyk M, Kvedariene V, Larenas-Linnemann DE, Lemonnier N, Lodrup Carlsen KC, Louis R, Makela M, Makris M, Maurer M, Momas I, Morais-Almeida M, Mullol J, Naclerio RN, Nadeau K, Nadif R, Niedoszytko M, Okamoto Y, Ollert M, Papadopoulos NG, Passalacqua G, Patella V, Pawankar R, Pham-Thi N, Pfaar O, Regateiro FS, Ring J, Rouadi PW, Samolinski B, Sastre J, Savouré M, Scichilone N, Shamji MH, Sheikh A, Siroux V, Sousa-Pinto B, Standl M, Sunyer J, Taborda-Barata L, Toppila-Salmi S, Torres MJ, Tsiligianni I, Valovirta E, Vandenplas O, Ventura MT, Weiss S, Yorgancioglu A, Zhang L, Abdul Latiff AH, Aberer W, Agache I, Al-Ahmad M, Alobid I, Ansotegui IJ, Arshad SH, Asayag E, Barbara C, Baharudin A, Battur L, Bennoor KS, Berghea EC, Bergmann KC, B… See abstract for full author list ➔ Bousquet J, et al. Among authors: buhl r. Allergy. 2023 May;78(5):1169-1203. doi: 10.1111/all.15679. Epub 2023 Apr 10. Allergy. 2023. PMID: 36799120 Free article. Review.
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Reddel HK, et al. Among authors: buhl r. Am J Respir Crit Care Med. 2022 Jan 1;205(1):17-35. doi: 10.1164/rccm.202109-2205PP. Am J Respir Crit Care Med. 2022. PMID: 34658302 Free PMC article.
The Treatment of Mild and Moderate Asthma in Adults.
Lommatzsch M, Buhl R, Korn S. Lommatzsch M, et al. Among authors: buhl r. Dtsch Arztebl Int. 2020 Jun 19;117(25):434-444. doi: 10.3238/arztebl.2020.0434. Dtsch Arztebl Int. 2020. PMID: 32885783 Free PMC article. Review.
Tezepelumab in patients with allergic and eosinophilic asthma.
Caminati M, Buhl R, Corren J, Hanania NA, Kim H, Korn S, Lommatzsch M, Martin N, Matucci A, Nasser SM, Pavord ID, Domingo C. Caminati M, et al. Among authors: buhl r. Allergy. 2024 May;79(5):1134-1145. doi: 10.1111/all.15986. Epub 2023 Dec 26. Allergy. 2024. PMID: 38146651 Review.
Pioneering a paradigm shift in asthma management: remission as a treatment goal.
Lommatzsch M, Buhl R, Canonica GW, Ribas CD, Nagase H, Brusselle GG, Jackson DJ, Pavord ID, Korn S, Milger K, Taube C, Virchow JC. Lommatzsch M, et al. Among authors: buhl r. Lancet Respir Med. 2024 Feb;12(2):96-99. doi: 10.1016/S2213-2600(23)00415-0. Epub 2023 Dec 7. Lancet Respir Med. 2024. PMID: 38071999 No abstract available.
533 results